Form D · Biotechnology

Metera Pharmaceuticals Inc.

Somerville, MA · CIK 0001693559

Offering snapshot reported Jun 11, 2018 · SEC filing

Reported sold: $8.55M
Investors reported: 1
Minimum accepted: $0
First sale: Dec 15, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$4,150,000 → $8,550,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 11, 2018	Amendment	$8,550,000	$4,400,000vs Dec 30, 2016	1	SEC filing
Jan 10, 2017	Amendment	$4,150,000	$0vs Dec 30, 2016	1	SEC filing
Dec 30, 2016	Initial	$4,150,000	No comparison	1	SEC filing

Offering details

Securities: Other
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-277409

Convertible Debt

Source: Form D, filed Jun 11, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Meredith C. Fisher, Ph.D.	Director
Marc Lenburg	Director, Executive
Marc Lenburg, Ph.D.	Director, Executive
Vijay Murthy	Director
Vijay Murthy, Ph.D.	Director
Avrum Spira	Executive
Avrum Spira, M.D.	Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

240 Elm Street 2nd Floor
Somerville, MA, 02144